OECD - PowerPoint PPT Presentation

1 / 37
About This Presentation
Title:

OECD

Description:

Creating a Humane and Efficient Approach to Developmental Neurotoxicity Testing-TestSmart DNT ... The Test Guidelines Programme (TGP) Established 1981 ... – PowerPoint PPT presentation

Number of Views:685
Avg rating:3.0/5.0
Slides: 38
Provided by: oecd8
Category:
Tags: oecd | tgp

less

Transcript and Presenter's Notes

Title: OECD


1
OECD Test Guidelines Adoption Process Patric
Amcoff Test Guidelines Programme Environment,
Health and Safety Division OECD Paris,
France Creating a Humane and Efficient Approach
to Developmental Neurotoxicity Testing-TestSmart
DNT Reston, Virginia, 13-15 March 2006
2
Outline of Presentation
  • OECD
  • The Test Guidelines Programme
  • OECD Test Guideline Submission and Adoption
    Process
  • Status of draft DNT Test Guideline 426
  • Future Improvements of TG 426!

3
The Organisation for Economic Co-operation and
Development
4
What is the OECD?
A forum in which governments work together to
address the economic, social and environmental
challenges of interdependence and globalisation
A provider of comparative data, analysis and
forecasts to underpin multilateral co-operation
5
A tool for governments
  • Born after World War II as the Organisation for
    European Economic Co-operation (OEEC) to
    coordinate the Marshall Plan
  • Transformed in 1961 into the Organisation for
    Economic Co-operation and Development (OECD) with
    trans-Atlantic and then global reach
  • Today the OECD has 30 member countries
  • More than 70 developing and transition economies
    are engaged in working relationships with the
    OECD

6
A global outreach
OECD Member Countries
Countries/Economies Engaged in Working
Relationships with the OECD
7
OECDs mission
  • To promote policies designed
  • to achieve sustainable economic growth and
    employment and rising standards of living in
    member countries while maintaining financial
    stability, so contributing to the development of
    the world economy
  • to assist sound economic expansion in member
    countries and other countries in the process of
    economic development
  • to contribute to growth in world trade on a
    multilateral, non-discriminatory basis

8
Who drives OECD work?
Council
Oversight and strategic direction
Representatives of member countries and of the
European Commission decisions taken by consensus
Committees
Secretariat
Discussion and implementation
Analysis and proposals
Secretary-General Deputy Secretaries-General Dire
ctorates
Representatives of member countries and
countries with Observer status work with the OECD
Secretariat on specific issues
Annual budget 188 million euros Funded by
member countries
9
The OECD Secretariat
Works in two official languages English and
French Staff members are international civil
servants No quota system for national
representation
2300 staff at Paris headquarters
10
The Test Guidelines Programme (EHS/ENV)
11
The Test Guidelines Programme (TGP)
  • Established 1981
  • MAIN TASK Develop and revise Test Guidelines for
    the testing of chemicals for human health and the
    environment
  • Original publication in 1981 51 TGs
  • Today 100 new or updated Guidelines
  • At presently 80 projects in the work-plan
  • Special activities Endocrine Disrupters Testing
    and Assessment (EDTA VMG mammalian, eco and
    non-animal)

12
OECD Council Decision (1981)Mutual Acceptance of
Data (MAD)
  • Data generated in the testing of chemicals in an
    OECD Member Country in accordance with OECD Test
    Guidelines and OECD Principles of Good Laboratory
    Practice (GLP) shall be accepted in other Member
    Countries for purposes of assessment and other
    uses relating to the protection of man and the
    environment.
  • Avoids duplication of testing by industry
  • Avoids non-tariff trade barriers
  • Reduces the number of laboratory animals used

13
Publication of OECD Test Guidelines
  • Test Guidelines are legal instruments in OECD
    Member countries. There are 4 series
  • 100 - Physical-Chemical Properties
    (blue)
  • 200 - Effects on Biotic Systems
    (green)
  • 300 - Degradation and Accumulation (yellow)
  • 400 - Health Effects (pink)
  • (500 Endocrine Disruption!)
  • Guidance Documents - GD (Non-binding)
  • Detailed Review Papers DRP (Non-binding)
  • Background Review Papers BRD (Non-binding)

14
Decision Layers
15
THE OECD SUBMISSION AND ADOPTION PROCESS
16
(No Transcript)
17
Standard Project Submission Form (SPSF)-
Essential criteria
  • Defined regulatory need/Data requirement
  • Contributes to the International Harmonisation
    of Hazard and Risk Assessment
  • Addresses a health or environmental concern
  • Considerable support from Member countries
  • Lead country or Stakeholder identified

18
Standard Project Submission Form (SPSF)-
Desirable criteria
  • Test Guideline intended for general/broad use
  • Scientifically valid, reliable and relevant
  • Addresses endpoints not yet covered
  • Existing national/regional protocols as a basis
  • Animal welfare concerns are addressed
  • Contributes to saving resources
  • For Guidance Documents
  • essential or helpful
  • linked to (a) specific TGs or for general
    guidance

19
(No Transcript)
20
Common Stumbling-blocks in the Development Process
  • Material supporting the performance/validity of
    the test is not attached or of poor quality
  • Statistical evaluations, scientific references,
    validation reports, peer review reports, etc.
  • Validation criteria outlined in OECD GD No.34 ? ?
  • A poorly written draft Test Guideline
  • A poorly defined/or changed regulatory purpose of
    the TG
  • Low level of commitment by the lead country
  • Need for Expert Consultation or DRP

21
OECD Validation Criteria
  • Available in
  • GUIDANCE DOCUMENT NO. 34 ON THE VALIDATION AND
    INTERNATIONAL ACCEPTANCE OF NEW OR UPDATED TEST
    METHODS FOR HAZARD ASSESSMENT (2005)
  • Applicable to all sorts of tests
  • Solna principles from WSs in 1996 and 2002 based
    on criteria from ICCVAM and ECVAM
  • Criteria for principles of validation
  • Criteria for principles of regulatory acceptance
  • Updated Test Guidelines need to meet the same
    requirements as new TGs
  • Patented tests (e.g., Corrositex)

22
Common Stumbling-blocks in the Development Process
  • Material supporting the performance/validity of
    the test is not attached or of poor quality
  • Statistical evaluations, scientific references,
    validation reports, peer review reports, etc.
  • Validation criteria outlined in GD No.34 ?
  • A poorly written draft Test Guideline
  • A poorly defined/or changed regulatory purpose of
    the TG
  • Low level of commitment by the lead country
  • Need for Expert Consultation or DRP

23
(No Transcript)
24
Example of regulatory acceptability at OECD level
for a test method developed in the EU
  • RD 3-10 years !?
  • Pre-validation 2 years
  • Validation 3 years
  • Peer review 2 years
  • EU regulatory acceptance 2 years
  • OECD regulatory acceptance 2 years

25
Refocusing of the Test Guidelines Programme
  • Main aim To more efficiently develop new or
    revised validated Test Guidelines that meet the
    regulatory need of Member countries
  • Better control of new proposals
  • Lead countries need to clearly state their degree
    of commitment
  • timelines for deliveries
  • number of researchers involved
  • estimated costs, etc.
  • Revision of the SPSF and Guidance Document No.1
    on Test Guidelines Development underway

26
Status and Background of Draft Test Guideline 426
(DNT)
27
Status of draft Test Guideline 426 (DNT)
  • Meetings in Ottawa (March-95) and Copenhagen
    (June-95) initiated the development of
  • Test Guideline 426 for Developmental
    Neurotoxicity
  • Guidance Document No.20 for Neurotoxicity Testing
    (adopted 2004)
  • Guidance Document No. 43 for Mammalian
    Reproductive Testing and Assessment (2006-2nd
    draft)

28
Development of TG 426
  • Consultation Meeting of Experts in Copenhagen,
    June 1996
  • Drafting of Guideline proposal lead by USA and
    Denmark
  • Submission of 1st draft to the OECD Secretariat
    in February 1998
  • 1st Circulation to the WNT in December 1998

29
Development of TG 426
  • Revision of the draft TG 426 based on comments
    received
  • Revised 2nd Draft TG circulated to WNT in
    October 1999
  • Comments received from 11 Member Countries and
    BIAC
  • Ad hoc Expert Group established
  • Lead by the Secretariat

30
Development of TG 426
  • The preferred approach by the 12th WNT (2000)
    was
  • Joint Meeting of ILSI and OECD on Developmental
    Neurotoxicity Testing, October, 2000
  • Technical agreement on preferred approach at the
    meeting
  • Revision of the Draft Test Guideline Proposal
  • Circulation of a 3rd revised version to the WNT
    in December 2000

31
Development of TG 426
  • A revised 4th version of TG426 was circulated to
    the WNT in September 2003
  • 8 Member countries, EC, BIAC and ICAPO commented
  • Due to the severity of comments the Secretariat
    consulted with Dr. Crofton of US EPA
  • Expert Consultation Meeting was held in May 2005
    at MHLW in Tokyo to resolve the last blocking
    issues

32
Development of TG 426
  • A 5th version will be circulated to the WNT for
    comments in March/April 2006 together with a
    supportive retrospective performance assessment
    document
  • The nature and severity of comments will
    determine how to move ahead
  • Need for Lead Country!

33
Future Improvements of TG 426
34
Future Improvements of TG 426
  • Dialogue needed between researchers and
    regulators
  • Need for new technologies (omics) as prescreens
  • Paradigm shift in regulatory toxicology REACH
    as a driving force!
  • Need for diversified testing and development of
    testing strategies for specific DNT endpoints
  • Implications for MAD!
  • TGs 404/405 Appendices Tiered Testing
  • EDTA Conceptual Framework as an example!?

35
The OECD Conceptual Framework for Testing and
Assessment of Endocrine Disrupters as agreed by
the EDTA6 (2002)
36
Synopsis
  • OECD Test Guidelines are legally binding
    instruments in OECD member countries (MAD)
  • The Test Guideline submission and adoption
    process is time consuming, however, when
    consensus is reached the regulatory
    implementation is usually rapid
  • The most common factors that delay Test Guideline
    development is lacking information on the
    performance and validation status of the test
    method
  • The draft TG 426 will be circulated to the WNT
    in spring 2006 and hopefully adopted during 2006
  • Severity of comments will determine the future of
    TG426!
  • New strategies for (DNT) testing should be
    discussed at the WNT and JM

37
Contact details
  • www.oecd.org
  • Patric.Amcoff_at_oecd.org
Write a Comment
User Comments (0)
About PowerShow.com